KR102314825B1 - 세포 배양 방법 - Google Patents

세포 배양 방법 Download PDF

Info

Publication number
KR102314825B1
KR102314825B1 KR1020167015012A KR20167015012A KR102314825B1 KR 102314825 B1 KR102314825 B1 KR 102314825B1 KR 1020167015012 A KR1020167015012 A KR 1020167015012A KR 20167015012 A KR20167015012 A KR 20167015012A KR 102314825 B1 KR102314825 B1 KR 102314825B1
Authority
KR
South Korea
Prior art keywords
cells
delete delete
serum
cell
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167015012A
Other languages
English (en)
Korean (ko)
Other versions
KR20160070167A (ko
Inventor
마리안 준 스텀
Original Assignee
아이소포젠 피티와이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013904257A external-priority patent/AU2013904257A0/en
Application filed by 아이소포젠 피티와이 리미티드 filed Critical 아이소포젠 피티와이 리미티드
Publication of KR20160070167A publication Critical patent/KR20160070167A/ko
Application granted granted Critical
Publication of KR102314825B1 publication Critical patent/KR102314825B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020167015012A 2013-11-04 2014-11-03 세포 배양 방법 Active KR102314825B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013904257 2013-11-04
AU2013904257A AU2013904257A0 (en) 2013-11-04 Cell culture method
PCT/AU2014/001031 WO2015061839A1 (en) 2013-11-04 2014-11-03 Cell culture method

Publications (2)

Publication Number Publication Date
KR20160070167A KR20160070167A (ko) 2016-06-17
KR102314825B1 true KR102314825B1 (ko) 2021-10-20

Family

ID=53003004

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167015012A Active KR102314825B1 (ko) 2013-11-04 2014-11-03 세포 배양 방법

Country Status (14)

Country Link
US (2) US9868936B2 (cg-RX-API-DMAC7.html)
EP (1) EP3066193B1 (cg-RX-API-DMAC7.html)
JP (2) JP6643999B2 (cg-RX-API-DMAC7.html)
KR (1) KR102314825B1 (cg-RX-API-DMAC7.html)
CN (1) CN105765059B (cg-RX-API-DMAC7.html)
AU (1) AU2014344795B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016009753B1 (cg-RX-API-DMAC7.html)
CA (1) CA2929333C (cg-RX-API-DMAC7.html)
ES (1) ES2984009T3 (cg-RX-API-DMAC7.html)
IL (1) IL245392B (cg-RX-API-DMAC7.html)
MX (1) MX2016005824A (cg-RX-API-DMAC7.html)
RU (1) RU2016119489A (cg-RX-API-DMAC7.html)
SG (1) SG11201603407VA (cg-RX-API-DMAC7.html)
WO (1) WO2015061839A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012048093A2 (en) 2010-10-08 2012-04-12 Osiris Therapeutics, Inc. Enhanced msc preparations
WO2015061839A1 (en) * 2013-11-04 2015-05-07 Sturm Marian June Cell culture method
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
US10420802B2 (en) 2015-12-10 2019-09-24 Aesthetics Biomedical, Inc. Topical formulation for skin care
CN109104869B (zh) * 2016-04-27 2022-07-01 日本乐敦制药株式会社 表达细胞表面标记物的间充质干细胞、包含该间充质干细胞的药物组合物及其制备方法
US20180185421A1 (en) * 2016-08-29 2018-07-05 Tokyo Metropolitan Government Composition comprising fecal microbiota
CN108925548A (zh) * 2017-05-24 2018-12-04 西比曼生物科技(香港)有限公司 一种冻存细胞制剂及细胞复苏方式
WO2019102268A1 (en) 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
JPWO2020067443A1 (ja) * 2018-09-27 2021-08-30 テルモ株式会社 体細胞のシート化方法
CN110628700B (zh) * 2019-10-14 2023-10-17 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 一种用于筛选细胞培养条件的标准方法
KR20220143092A (ko) * 2020-02-19 2022-10-24 메조블라스트 인터내셔널 에스에이알엘 만성 이식편 대 숙주 질환의 치료 방법
WO2021176001A1 (en) 2020-03-05 2021-09-10 Mesoblast International Sàrl Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
US20230270791A1 (en) * 2020-07-31 2023-08-31 Rainbow (Rainbow Inc.) Platelet lysate derived from autologous platelets
US12577540B2 (en) 2020-12-10 2026-03-17 Sarepta Therapeutics, Inc. Suspension mode seed train development for adherent cells
EP4764493A1 (en) * 2024-12-18 2026-06-24 Beiersdorf AG Rejuvenating factors

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070020242A1 (en) 2003-03-27 2007-01-25 Ixion Biotechnology, Inc. Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
JP2007325593A (ja) 2001-02-14 2007-12-20 Leo T Furcht 多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞
JP2008520215A (ja) 2004-11-16 2008-06-19 ウニヴァズィテーツクリニークム ハンブルク−エッペンドルフ 骨髄幹細胞からインビトロで分化した網膜特異的細胞、その産生およびその使用
JP2017501740A (ja) 2013-11-04 2017-01-19 アイソポジェン ピーティーワイ リミテッド 細胞培養方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142914A0 (en) * 1998-11-09 2002-04-21 Consorzio Per La Gestione Del Serum free medium for chondrocyte-like cells
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
US7972767B2 (en) * 2005-05-09 2011-07-05 Olympus Corporation Method for culturing mesenchymal stem cell and method for producing biological tissue prosthesis
US7989205B2 (en) * 2005-10-06 2011-08-02 American Cryostem Corporation Cell culture media, kits and methods of use
EP1795588A1 (en) * 2005-12-07 2007-06-13 Cellerix, S.L. Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
WO2010043076A1 (zh) * 2008-10-17 2010-04-22 宁夏医科大学附属医院 适于临床应用的人胎盘间质细胞库的建立方法
WO2012149574A1 (en) * 2011-04-29 2012-11-01 Tissuetech, Inc. Methods of isolating cells
CN102965335A (zh) * 2011-09-01 2013-03-13 北京清美联创干细胞科技有限公司 用于间充质干细胞培养的试剂盒及其应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007325593A (ja) 2001-02-14 2007-12-20 Leo T Furcht 多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞
US20070020242A1 (en) 2003-03-27 2007-01-25 Ixion Biotechnology, Inc. Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
JP2008520215A (ja) 2004-11-16 2008-06-19 ウニヴァズィテーツクリニークム ハンブルク−エッペンドルフ 骨髄幹細胞からインビトロで分化した網膜特異的細胞、その産生およびその使用
JP2017501740A (ja) 2013-11-04 2017-01-19 アイソポジェン ピーティーワイ リミテッド 細胞培養方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Mol Ther. 9(5):747-56 (2004.05.)*
Stem Cells. 24(10):2232-43 (2006.10.)*

Also Published As

Publication number Publication date
US9868936B2 (en) 2018-01-16
CN105765059B (zh) 2021-05-25
JP6947430B2 (ja) 2021-10-13
CA2929333A1 (en) 2015-05-07
EP3066193A1 (en) 2016-09-14
US20150307844A1 (en) 2015-10-29
EP3066193B1 (en) 2024-07-10
IL245392A0 (en) 2016-06-30
EP3066193C0 (en) 2024-07-10
BR112016009753B1 (pt) 2023-11-28
IL245392B (en) 2018-10-31
AU2014344795B2 (en) 2016-05-26
RU2016119489A (ru) 2017-12-11
JP2020022486A (ja) 2020-02-13
US20180112181A1 (en) 2018-04-26
CA2929333C (en) 2023-09-12
EP3066193A4 (en) 2017-04-19
AU2014344795A1 (en) 2016-03-10
US11041144B2 (en) 2021-06-22
ES2984009T3 (es) 2024-10-28
JP2017501740A (ja) 2017-01-19
SG11201603407VA (en) 2016-05-30
CN105765059A (zh) 2016-07-13
KR20160070167A (ko) 2016-06-17
BR112016009753A2 (pt) 2018-05-02
WO2015061839A1 (en) 2015-05-07
MX2016005824A (es) 2016-11-18
JP6643999B2 (ja) 2020-02-12

Similar Documents

Publication Publication Date Title
JP6947430B2 (ja) 細胞培養方法
JP6560381B2 (ja) 脂肪組織または胎盤組織に由来する接着性細胞および治療におけるその使用
JP5599568B2 (ja) 分娩後由来細胞を用いた末梢血管疾患の治療
JP7563976B2 (ja) 歯髄由来細胞の製造方法
JP6931656B2 (ja) クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞
JP6193214B2 (ja) 歯髄由来の多能性幹細胞の製造方法
JPWO2019132025A1 (ja) 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物
JP7152389B2 (ja) 間葉系幹細胞を含む細胞集団とその製造方法、間葉系幹細胞及び医薬組成物
HK1228953A1 (en) Cell culture method
HK1228953B (en) Cell culture method
WO2022210574A1 (ja) 筋ジストロフィー治療剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160603

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20191031

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200927

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20210728

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20211013

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20211014

End annual number: 3

Start annual number: 1

PG1601 Publication of registration